Related Experiment Videos
Etiology and management of chylothorax following pediatric heart surgery
Michael Milonakis1, Andrew C Chatzis, Nikolaos M Giannopoulos
1Department of Pediatric and Congenital Cardiac Surgery, Onassis Cardiac Surgery Center, Athens, Greece. milonakis@ath.forthnet.gr
Insights
Conservative management effectively treats most cases of chylothorax following congenital heart surgery (CHD). Surgical pleurodesis is successful for refractory cases, ensuring positive outcomes for this rare complication.
Area of Science:
- Pediatric Cardiac Surgery
- Thoracic Surgery
- Critical Care Medicine
Background:
- Chylothorax is a rare but challenging complication after congenital heart surgery (CHD).
- This study reviews institutional experience managing postoperative chylothorax in pediatric patients.
Purpose of the Study:
- To evaluate the management strategies and outcomes of chylothorax in pediatric patients undergoing congenital heart defect repair.
Main Methods:
- A retrospective review of 1341 pediatric patients undergoing CHD surgery between 1997 and 2006.
- 18 patients (1.3%) developed postoperative chylothorax and were treated with drainage, controlled nutrition, and somatostatin (adjunctively in 6 patients).
- Surgical intervention was reserved for persistent cases unresponsive to maximal conservative therapy.
Main Results:
- No deaths occurred among the 18 patients.
- Conservative therapy resolved chylothorax in 15 patients (83.3%).
- Three patients required thoracotomy with pleurodesis for persistent lymph leak, with two previously failing chemical pleurodesis.
Conclusions:
- Postoperative chylothorax is infrequent after CHD surgery, even without elevated venous pressure.
- Conservative management is effective for the majority of cases.
- Surgical pleurodesis is a successful option for refractory chylothorax after congenital heart surgery.
Background:
Chylothorax after congenital heart surgery (CHD) is a potentially challenging complication. The purpose of this study was to review our experience with the management of chylothorax following congenital heart surgery.
Methods:
Between September 1997 and August 2006, of 1341 pediatric patients undergoing correction of congenital heart disease in our institution, 18 (1.3%) developed chylothorax postoperatively. Surgical procedures included tetralogy of Fallot repair in 10 patients, ventricular septal defect closure (one), atrial septal defect with pulmonary stenosis repair (one), Fontan procedure (three), coarctation of the aorta repair (one), aortopulmonary shunt (one), and ligation of patent ductus arteriosus in one patient. All patients followed a therapeutic protocol including complete drainage of chyle collection and controlled nutrition. Somatostatin was used adjunctively in six (33.3%) patients. Surgical intervention was reserved for persistent lymph leak despite maximal therapy. Following resolution of chylothorax, a medium-chain triglyceride diet was implemented for six weeks.
Results:
There were no deaths. Fifteen patients (83.3%) responded to conservative therapy. Lymph leak ranged from 2.5 to 14.7 mL/kg per day for 8 to 42 days. Three patients with persistent drainage required thoracotomy with pleurodesis to achieve resolution, in two of which previously attempted chemical pleurodesis with doxycycline proved ineffective. Duration of lymph leak in this subgroup ranged from 15 to 47 days with 5.1 to 7.4 mL/kg per day output.
Conclusions:
Postoperative chylothorax is an infrequent complication of surgery for congenital heart disease and can occur even after median sternotomy in the absence of pathologically elevated venous pressure or Fontan circulation. Although hospitalization can be prolonged, conservative therapy is effective in most cases, while surgical pleurodesis proved successful in the refractory cases.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pneumothorax II: Pathophysiology